Interaction of AlkylHalides with the Di -ironoctacarbonylate Anion : the Crystal Structures of the Tetraethylammonium Salts of the p-Acetyl-C1(Fel, Fe2)O(Fe1, Fe3) aonacarbonyl-friangulo-triferrate and p2-Carbonylnonacarbonyl -p3 -2,4dioxapentylidyne -triangulotriferrate Anions
1-5-1 Chofugaoka CHOFU-CITY TOKYO 182-8585 JAPAN Some Cu(II) transition complexes, coordinated by pyrimidines or related compounds which have meta-coordination positions, showed magnetic interactions (Ishida and Nogami 1997). Crystal structure analyses revealed that the one-dimensional polymer structures bridged via meta-N ligands on the axial-equatorial position are essential for the ferromagnetic properties (M. Yasui et al., 2001). In the case of [Cu(hfac) (qz)] , where qz=quinazoline and hfac=1,1,1,5,5,5-hexafluoropentane-2,4-dionate, the coordination mode of the meta-N atoms is an axial-axial at room temperature. The bond lengths around the Cu1 atom are significantly changed at 120 K, that is, N1-Cu1 2.182 to 2.043 and O1-Cu1 2.070 to 2.189 Å, while N2-Cu2 and O2-Cu2 remain unchanged. Thus the coordination mode is an axial-equatorial at 120 K. No evidence of the first-order transitions was observed from DSC and the lattice constants. The expansion coefficient of the lattice volume, however, changed at about 210 K. This corresponds that the structural transition is a secondorder. The detailed temperature-dependent structure analyses showed that Cu1-O1 and Cu1-N1 lengths changed gradually and the coordination modes were changed at 255 K. The analysis of the rigid-molecular vibration of the quinazoline moiety revealed that these gradual changes ascribed to the molecular rotation of the quinazoline ring.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.